Tag: AI
Top News
Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights...
Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.
- Our Sponsors Ad -
